American State Bank (Iowa)’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

American State Bank (Iowa)’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,564	Closed	-$65.1K	–	334
2023 Q4	$65.1K	Hold	1,564	–	–	0.04%	180
2023 Q3	$62.2K	Hold	1,564	–	–	0.04%	178
2023 Q2	$64.1K	Sell	1,564 -36	-2%	-$1.49K	0.04%	181
2023 Q1	$65.6K	Hold	1,600	–	–	0.05%	180
2022 Q4	$65.5K	Hold	1,600	–	–	0.05%	179
2022 Q3	$64.3K	Buy	+1,600	New	+$68.4K	0.06%	176

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

American State Bank (Iowa)'s XPH Position: Q1 2024 in Review

American State Bank (Iowa) sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2024, closing a stake of 1,564 shares — an estimated $65.1K sold.

American State Bank (Iowa) first reported a position in XPH in Q3 2022 and held it in 6 quarters. The position peaked at $65.6K in Q1 2023. 73 funds tracked by Wall St. Rank hold XPH as of Q1 2024.

American State Bank (Iowa) reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2024 after selling out during the quarter.
American State Bank (Iowa) sold 1,564 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2024, an estimated $65.1K.
American State Bank (Iowa) first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2022 and held it in 6 quarters.
American State Bank (Iowa)'s State Street SPDR S&P Pharmaceuticals ETF position peaked at $65.6K in Q1 2023.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2024.

Based on American State Bank (Iowa)'s 13F filing for Q1 2024, filed 14 Apr 2026.